Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Aclaris Therapeutics (NASDAQ: ACRS) announced that Dr. Neal Walker, Interim President & CEO, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. The event will take place on June 11, 2024, at 11:20 AM ET in Miami, Florida.
The chat will be webcasted and accessible via the company's website, where it will be archived for at least 30 days.
- Participation in a high-profile event like the Goldman Sachs Global Healthcare Conference can increase visibility and credibility.
- Opportunity for company leadership to present their strategic vision and updates to a broad audience of investors and industry leaders.
- No new product data or financial results were announced, which might not satisfy investors looking for concrete updates.
- Potentially high expectations from investors regarding the presentation that, if unmet, could negatively affect stock performance.
WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will participate in a fireside chat during the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 11:20 AM ET in Miami, Florida.
A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.
Aclaris Therapeutics Contact:
FAQ
When will Aclaris Therapeutics participate in the Goldman Sachs 45th Annual Global Healthcare Conference?
Who will represent Aclaris Therapeutics at the Goldman Sachs conference?
Where can I access the webcast of Aclaris Therapeutics’ presentation at the conference?
What is the stock symbol for Aclaris Therapeutics?
